Cargando…
Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly
The feasibility of the noninvasive assessment of blood ‘coagulability’ (the tendency to coagulate) has been tested by using a novel device, the Thrombo-Monitor. It monitors, by using the principles of near infra-red (NIR) dynamic light scattering, the tendency of blood to create clots. The Thrombo-M...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262344/ https://www.ncbi.nlm.nih.gov/pubmed/22287870 http://dx.doi.org/10.2147/JBM.S13544 |
_version_ | 1782221709132169216 |
---|---|
author | Lerman, Yaffa Werber, Moshe M Fine, Ilya Kemelman, Polina |
author_facet | Lerman, Yaffa Werber, Moshe M Fine, Ilya Kemelman, Polina |
author_sort | Lerman, Yaffa |
collection | PubMed |
description | The feasibility of the noninvasive assessment of blood ‘coagulability’ (the tendency to coagulate) has been tested by using a novel device, the Thrombo-Monitor. It monitors, by using the principles of near infra-red (NIR) dynamic light scattering, the tendency of blood to create clots. The Thrombo-Monitor observes the very initial changes of blood viscosity, which occurs due to the temporarily induced stasis of capillary blood of the finger. One hundred and fifteen patients aged >65 years (matched by age and sex) participated in the study. Patients were initially divided into four groups based on the patient’s medical therapy. The study groups were: warfarin, enoxaparin, aspirin and/or clopidogrel, and a control group. The medications were given according to the patient’s comorbidities (eg, atrial fibrillation [AF], status post pulmonary embolism [S/p PE], status post cerebrovascular accident [S/p CVA]). The Thrombo-Monitor Index (TMI) is a noninvasive index, derived on the basis of laboratory test results of international normalized ratio (INR) and prothrombin time (PT) values. For the group of patients who were treated only with warfarin, TMI was adjusted by using the jackknife statistical approach to create maximum correlation and linearity with INR and PT values that ranged from 1.1 to 5.0. For all warfarin patients (N = 35) the TMI was found to have a good correlation with INR and PT values (R(2) = 0.64, P < 0.00001); mean TMI = 1.86 (SD = 0.91); mean INR and PT = 2.3 (SD = 0.91). The calibration curve thus generated was used to calculate the TMI for all other groups: aspirin group, mean TMI = 1.3 (SD = 0.14, N = 23), corresponding approximately to INR and PT values of 1.036; enoxaparin group (N = 24), mean TMI = 1.34 (SD = 0.304), corresponding to mean INR and PT values of 1.07 (SD = 0.3); control group, INR and PT ≥ 1 (N = 32), mean TMI = 1.24 (SD = 0.32). R(2) of all control and warfarin patients (N = 67) was 0.55 (P < 0.00001). In summary, the newly introduced TMI index is significantly correlated with INR and PT values. |
format | Online Article Text |
id | pubmed-3262344 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-32623442012-01-27 Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly Lerman, Yaffa Werber, Moshe M Fine, Ilya Kemelman, Polina J Blood Med Original Research The feasibility of the noninvasive assessment of blood ‘coagulability’ (the tendency to coagulate) has been tested by using a novel device, the Thrombo-Monitor. It monitors, by using the principles of near infra-red (NIR) dynamic light scattering, the tendency of blood to create clots. The Thrombo-Monitor observes the very initial changes of blood viscosity, which occurs due to the temporarily induced stasis of capillary blood of the finger. One hundred and fifteen patients aged >65 years (matched by age and sex) participated in the study. Patients were initially divided into four groups based on the patient’s medical therapy. The study groups were: warfarin, enoxaparin, aspirin and/or clopidogrel, and a control group. The medications were given according to the patient’s comorbidities (eg, atrial fibrillation [AF], status post pulmonary embolism [S/p PE], status post cerebrovascular accident [S/p CVA]). The Thrombo-Monitor Index (TMI) is a noninvasive index, derived on the basis of laboratory test results of international normalized ratio (INR) and prothrombin time (PT) values. For the group of patients who were treated only with warfarin, TMI was adjusted by using the jackknife statistical approach to create maximum correlation and linearity with INR and PT values that ranged from 1.1 to 5.0. For all warfarin patients (N = 35) the TMI was found to have a good correlation with INR and PT values (R(2) = 0.64, P < 0.00001); mean TMI = 1.86 (SD = 0.91); mean INR and PT = 2.3 (SD = 0.91). The calibration curve thus generated was used to calculate the TMI for all other groups: aspirin group, mean TMI = 1.3 (SD = 0.14, N = 23), corresponding approximately to INR and PT values of 1.036; enoxaparin group (N = 24), mean TMI = 1.34 (SD = 0.304), corresponding to mean INR and PT values of 1.07 (SD = 0.3); control group, INR and PT ≥ 1 (N = 32), mean TMI = 1.24 (SD = 0.32). R(2) of all control and warfarin patients (N = 67) was 0.55 (P < 0.00001). In summary, the newly introduced TMI index is significantly correlated with INR and PT values. Dove Medical Press 2011-08-18 /pmc/articles/PMC3262344/ /pubmed/22287870 http://dx.doi.org/10.2147/JBM.S13544 Text en © 2011 Lerman et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Lerman, Yaffa Werber, Moshe M Fine, Ilya Kemelman, Polina Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly |
title | Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly |
title_full | Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly |
title_fullStr | Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly |
title_full_unstemmed | Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly |
title_short | Preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly |
title_sort | preliminary clinical evaluation of a noninvasive device for the measurement of coagulability in the elderly |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262344/ https://www.ncbi.nlm.nih.gov/pubmed/22287870 http://dx.doi.org/10.2147/JBM.S13544 |
work_keys_str_mv | AT lermanyaffa preliminaryclinicalevaluationofanoninvasivedeviceforthemeasurementofcoagulabilityintheelderly AT werbermoshem preliminaryclinicalevaluationofanoninvasivedeviceforthemeasurementofcoagulabilityintheelderly AT fineilya preliminaryclinicalevaluationofanoninvasivedeviceforthemeasurementofcoagulabilityintheelderly AT kemelmanpolina preliminaryclinicalevaluationofanoninvasivedeviceforthemeasurementofcoagulabilityintheelderly |